GRRO European Union

The European Union (EU) Subgroup proactively aims to develop collaborative relationships with various stakeholders in the EU, including EMA, national regulatory agencies, pharmacopeia, other standard-setting bodies, pharmaceutical industry, suppliers and other trade groups.  The Subgroup stays abreast of, and influences as appropriate, regulatory developments for OINDPs in the European Union.


GRRO European Union - June 2016

The GRRO European Union Working Group has conveyed consensus comments to the British Pharmacopoeia in its inhalation monographs policy document, and to the EMA regarding the OINDP quality guideline and OIP BE guideline.

See member benefits

Become an IPAC-RS member today Participation in IPAC-RS affords a variety of benefits including opportunities to shape the scientific and regulatory environment and tools to stay informed.

Sign Up

IPAC-RS members can sign up to receive our monthly update on IPAC-RS and regulatory developments.